13564 Federal Register / Vol. 80, No. 50 / Monday, March 16, 2015 / Notices 

the Director (OD) at the National 

Institutes of Health (NIH). 

Need and Use of Information 

Collection: This cross-site evaluation 

study will assess three desired 

outcomes: (1) Changes in understanding 

of career opportunities, confidence to 

make career decisions, and attitudes 

towards career opportunities; (2) 

reduced time to desired, non-training, 

non-terminal career opportunities, and 

reduced time in postdoctoral positions; 

and (3) creation/further development of 

institutional infrastructure to continue 

BEST-like activities. The first two 

desired outcomes are for graduate 

students and postdoctoral scientists 

from the awardee institutions, the third 

desired outcome is for the awardee 

institutions. The findings will be used 

to: (1) Identify and document best 

practices in the field of biomedical 

research training, (2) inform the NIH 

Director, DPCPSI Director, and OSC 

Director on the outcomes of the BEST 

program, and (3) disseminate best 

practices and outcomes of the BEST 

program to biomedical training 

programs and the research community. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

8,106. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Number of 

respondents 

Frequency of 

response 

Average time 

per response 

(in hours) 

Total annual 

hour burden 

Graduate Student—Entrance Survey (online survey) ..................................... 4,519 1 20/60 1,506 

Graduate Student—Interim Survey (online survey) ......................................... 11,296 1 15/60 2,824 

Graduate Student—Exit Survey (online survey) .............................................. 3,012 1 15/60 753 

Graduate Student—Post-Exit 2-year Survey (online survey) .......................... 3,012 1 15/60 753 

Postdoctoral Scientist—Entrance Survey (online survey) ............................... 3,137 1 20/60 1,046 

Postdoctoral Scientist—Exit Survey (online survey) ....................................... 2,091 1 15/60 523 

Postdoctoral Scientist—Post-Exit 2-year Survey (online survey) .................... 2,091 1 15/60 523 

Program Staff—Annual Phone Interview ......................................................... 83 1 1 83 

PIs—Data Form Section 1 (reported annually) ............................................... 17 1 180/60 51 

PIs—Data Form Section 2 (reported annually) ............................................... 17 1 90/60 26 

PIs—Data Form Section 3 (reported once) ..................................................... 17 1 30/60 9 

PIs—Data Form Section 4 (reported once) ..................................................... 17 1 30/60 9 

Dated: March 10, 2015. 

Lawrence A. Tabak, 

Deputy Director, National Institutes of Health. 

[FR Doc. 2015–05932 Filed 3–13–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–15–0932] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) has submitted the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. The notice for 

the proposed information collection is 

published to obtain comments from the 

public and affected agencies. 

Written comments and suggestions 

from the public and affected agencies 

concerning the proposed collection of 

information are encouraged. Your 

comments should address any of the 

following: (a) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the functions of the agency, including 

whether the information will have 

practical utility; (b) Evaluate the 

accuracy of the agencies estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; (d) Minimize the burden of 

the collection of information on those 

who are to respond, including through 

the use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and (e) Assess information 

collection costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570 or 

send an email to omb@cdc.gov. Written 

comments and/or suggestions regarding 

the items contained in this notice 

should be directed to the Attention: 

CDC Desk Officer, Office of Management 

and Budget, Washington, DC 20503 or 

by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

Data Collection for Evaluation of 

Education, Communication, and 

Training Activities (OMB No. 0920– 

0932, expires 05/31/2015)—Revision— 

National Center for Emerging and 

Zoonotic Infectious Diseases (NCEZID), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

The Centers for Disease Control and 

Prevention (CDC) Division of Global 

Migration and Quarantine (DGMQ) is 

requesting a revision of a currently 

approved generic clearance to conduct 

evaluation research. This will help CDC 

plan and implement health 

communication, education, and training 

activities to improve health and prevent 

the spread of disease. These activities 

include communicating with 

international travelers and other mobile 

populations, training healthcare 

providers, and educating public health 

departments and other federal partners. 

The information collection for which 

the revision is sought is in accordance 

with DGMQ’s mission to reduce 

morbidity and mortality among 

immigrants, refugees, travelers, 

expatriates, and other globally mobile 

populations, and to prevent the 

introduction, transmission, or spread of 

communicable diseases from foreign 

countries into the United States. This 

mission is supported by delegated legal 

authorities outlined in the Public Health 

Service (PHS) Act (42 U.S.C. 264) and 

in regulations that are codified in 42 

Code of Federal Regulations (CFR) parts 

70 and 71, and 34. 


Rmajette on DSK2VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 50 / Monday, March 16, 2015 / Notices 13565 

Since receiving initial approval for 

this generic, CDC has conducted five 

information collections. These 

information collections supported an 

Evaluation of Adapted Health Education 

Materials for LEP Spanish Speakers and 

Indigenous Migrants; Evaluation of the 

TravAlert Electronic Messaging System; 

a project entitled Scan This: 

Effectiveness of Quick Response Codes 

for Engaging International Panel 

Physicians; and two collections 

involving CDC’s Check and Report 

Ebola programs (CARE and CARE+) 

(The CARE+ evaluation is still 

underway as of the date of this notice). 

In order, these projects evaluated 

materials designed for specific 

audiences to determine if CDC’s 

methods for communicating key public 

health messages were translated 

appropriately for low-English 

proficiency residents in the United 

States, were effective in reaching 

travelers in airports, were useful in 

making CDC’s immigration medical 

exam technical instructions more 

accessible, and were helpful in reaching 

individuals and assessing their 

knowledge, attitudes, beliefs, and 

behaviors concerning enhanced 

screening for Ebola at U.S. ports of entry 

and follow-up under active monitoring. 

Approval of this revision of the 

generic information collection will 

allow DGMQ to continue to collect, in 

an expedited manner, information about 

the knowledge, attitudes, and behaviors 

of key audiences (such as refugees, 

immigrants, migrants, international 

travelers, travel industry partners, 

healthcare providers, non-profit 

agencies, customs brokers and 

forwarders, schools, state and local 

health departments) to help improve 

and inform these activities during both 

routine and emergency public health 

events. This generic OMB clearance will 

help DGMQ continue to refine these 

efforts in a timely manner, and will be 

especially valuable for communication 

activities that must occur quickly in 

response to public health emergencies. 

DGMQ staff will use a variety of data 

collection methods for this proposed 

project: Interviews, focus groups, 

surveys, and pre/post-tests. Depending 

on the research questions and audiences 

involved, data may be gathered inperson, by telephone, online, or using 

some combination of these formats. Data 

may be collected in quantitative and/or 

qualitative forms. Numerous audience 

variables will be assessed under the 

auspices of this generic OMB clearance. 

These include, but are not limited to, 

knowledge, attitudes, beliefs, behavioral 

intentions, practices, behaviors, skills, 

self-efficacy, and information needs and 

sources. Insights gained from evaluation 

research will assist in the development, 

refinement, implementation, and 

demonstration of outcomes and impact 

of communication, education, and 

training activities. 

DGMQ estimates involvement of 

37,500 respondents and 17,835 hours of 

burden for evaluation research activities 

each year. The collected information 

will not impose a cost burden on the 

respondents beyond that associated 

with their time to provide the required 

data. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses 

per 

respondent 

Average 

burden per 

response 

(in hours) 

General Public ...................................................... Focus Groups Screening form ............................. 2,100 1 10/60 

Healthcare Professionals ...................................... Focus Groups Screening form ............................. 900 1 10/60 

General Public ...................................................... Focus Group Guide .............................................. 1,050 1 1.5 

Healthcare Professionals ...................................... Focus Group Guide .............................................. 450 1 1.5 

General Public ...................................................... Interview Screening Form .................................... 1,400 1 10/60 

Healthcare Professionals ...................................... Interview Screening Form .................................... 600 1 10/60 

General Public ...................................................... Interview Guide .................................................... 700 1 1 

Healthcare Professionals Interviews .................... Interview Guide .................................................... 300 1 1 

General Public ...................................................... Survey Screening Forms ...................................... 10,500 1 10/60 

Healthcare Professionals ...................................... Survey Screening Forms ...................................... 4,500 1 10/60 

General Public ...................................................... Surveys ................................................................. 5,250 1 45/60 

Healthcare Professionals ...................................... Surveys ................................................................. 2,250 1 45/60 

General Public ...................................................... Pre/Post Tests ...................................................... 5,250 1 45/60 

Healthcare Professionals ...................................... Pre/Post Tests ...................................................... 2,250 1 45/60 

Leroy A. Richardson, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–05902 Filed 3–13–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration National 

Advisory Council; Notice of Meeting 

Pursuant to Public Law 92–463, 

notice is hereby given of the meeting of 

the Substance Abuse and Mental Health 

Service Administration’s (SAMHSA) 

National Advisory Council (NAC) on 

April 17, 2015. 

The meeting will include a recap of 

the April 16, 2015, meeting of the Joint 

National Advisory Council, an update 

from the SAMHSA Administrator, and 

discussions regarding health 

information technology, delivery system 

reform, and the ecological model of 

integration. 

The meeting is open to the public and 

will be held at the SAMHSA building, 

1 Choke Cherry Road, Rockville, MD 

20850. Attendance by the public will be 

limited to space available. Interested 

persons may present data, information, 

or views, orally or in writing, on issues 

pending before the Council. Written 

submissions should be forwarded to the 

contact person on or before April 7, 

2015. Oral presentations from the public 

will be scheduled at the conclusion of 

the meeting. Individuals interested in 

making oral presentations are 

encouraged to notify the contact on or 

before April 7, 2015. Five minutes will 

be allotted for each presentation. 

The meeting may be accessed via 

telephone and web conferencing will be 

available. To attend on site; obtain the 

call-in number, access code, and/or web 

access link; submit written or brief oral 

comments; or request special 

accommodations for persons with 


Rmajette on DSK2VPTVN1PROD with NOTICES